LONDON Too little is being done either to prevent pharmaceutical residues entering the environment or to assess the risks that poses, according to an OECD report. Most OECD member countries have risk lists and voluntary monitoring for certain pharmaceuticals in surface waters, but the majority of around 2,000 active pharmaceutical ingredients and their metabolites remain unmonitored and without environmental toxicity data.